IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -82.54% | -79.73% | -72.47% | -53.36% | -24.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -82.54% | -79.73% | -72.47% | -53.36% | -24.74% |
| Cost of Revenue | -52.55% | -56.90% | -53.96% | -35.44% | -7.18% |
| Gross Profit | -2,566.67% | -462.66% | -125.82% | -111.46% | -95.49% |
| SG&A Expenses | -49.89% | -38.50% | -39.51% | -34.91% | -30.02% |
| Depreciation & Amortization | 35.54% | 53.94% | 11.54% | 70.55% | 26.76% |
| Other Operating Expenses | -20.56% | -16.64% | -21.63% | -7.02% | 1.63% |
| Total Operating Expenses | -31.54% | -26.59% | -31.96% | -24.14% | -18.37% |
| Operating Income | 24.97% | 18.40% | 25.24% | 19.54% | 17.47% |
| Income Before Tax | 46.47% | 45.32% | 44.28% | 20.02% | 21.94% |
| Income Tax Expenses | -490.00% | -700.00% | 125.76% | 119.67% | 35.48% |
| Earnings from Continuing Operations | 46.91% | 45.74% | 44.09% | 19.82% | 21.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.91% | 45.74% | 44.09% | 19.82% | 21.93% |
| EBIT | 24.97% | 18.40% | 25.24% | 19.54% | 17.47% |
| EBITDA | 27.84% | 21.47% | 28.90% | 23.48% | 19.03% |
| EPS Basic | 66.81% | 56.65% | 48.04% | 34.92% | 38.33% |
| Normalized Basic EPS | 65.51% | 50.92% | 42.69% | 35.06% | 38.22% |
| EPS Diluted | 68.65% | 58.01% | 49.73% | 32.36% | 36.54% |
| Normalized Diluted EPS | 65.33% | 50.62% | 42.58% | 34.99% | 38.21% |
| Average Basic Shares Outstanding | 81.28% | 36.13% | 9.69% | 15.40% | 18.87% |
| Average Diluted Shares Outstanding | 80.84% | 35.76% | 9.60% | 15.45% | 18.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |